US President Donald Trump is reportedly considering imposing tariffs of 200 per cent or more on imported pharmaceuticals, a dramatic shift that could upend decades...
Pharmaceutical firms are expected to post 11 per cent year-on-year growth in both sales and EBITDA for the first quarter of Financial Year 2026 (Q1FY26),...
Agriculture, pharma, electronics, and engineering goods together accounted for over 50 per cent of India’s merchandise exports in 2024-25, according to government data, highlighting the...
In a move aimed at aligning US drug prices with global rates, President Donald Trump on Monday issued an executive order instructing pharmaceutical companies to...
India’s liberalised foreign direct investment (FDI) policy offers stability, predictability and sector-agnostic investment opportunities for global investors looking to tap into its vast and expanding...
White-collar hiring in India witnessed a healthy start to FY 2025-26, registering a 9 per cent year-on-year growth, according to a report on Thursday. The...
The Indian stock markets ended trading higher, but with muted gains on Tuesday. The BSE Sensex settled the session a little under 80,300, climbing 70...